Intangible Assets

12 Months Ended

Jun. 30, 2013

Intangible Assets

Intangible Assets

Note 8.  Intangible Assets

Intangible assets, net as of June 30, 2013 and 2012, consisted of the following:

	Gross Carrying Amount				Accumulated Amortization						Intangible Assets, Net
(In thousands)	2013		2012		2013			2012			2013		2012
JSP Marketing and Dist. Rights	$	16,062	$	16,062	$	(14,723	)	$	(12,939	)	$	1,339	$	3,123
Cody Labs Import License	582		582		(193		)	(154		)	389		428
Morphine Sulfate Oral Solution NDA	398		398		(51		)	(24		)	347		374
Other ANDA Product Rights(A)	600		600		(128		)	(96		)	472		504
	$	17,642	$	17,642	$	(15,095	)	$	(13,213	)	$	2,547	$	4,429

(A)  The amounts above include the product line covered by the ANDA’s purchased in August 2009 for $149 thousand.  These ANDA’s are not being amortized at this time and will not be amortized until such time as the Company begins shipping these products.

For the fiscal years ended June 30, 2013, 2012 and 2011, the Company incurred amortization expense of approximately $1.9 million, respectively.  There were no impairments related to intangible assets during fiscal year 2013, 2012 and 2011.

Future annual amortization expense consisted of the following:

(In thousands) Fiscal Year Ending June 30,	Annual Amortization Expense
2014	$	1,435
2015	97
2016	97
2017	97
2018	97
Thereafter	575
	$	2,398

The amounts above do not include the product line covered by the ANDA’s purchased in August 2009 for $149 thousand, as amortization will begin when the Company starts shipping these products.